Overexpression of GCH1 protects the heart from DCM and improves cardiac remodeling and dysfunction in a T1DM mouse heart model; therefore, GCH1 may serve as a new target for DCM therapy (70). This evidence concerns the gene GCH1 and familial dilated cardiomyopathy.